BeOne Medicines
ONC
#652
Rank
HK$278.14 B
Marketcap
HK$2,514
Share price
-2.56%
Change (1 day)
57.13%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Annual Reports

Thumbnail BeOne Medicines Annual Report 2023

Annual Report 2023

Language: English

View Annual Report
Thumbnail BeOne Medicines Annual Report 2022

Annual Report 2022

Language: English

View Annual Report
Thumbnail BeOne Medicines Annual Report 2021

Annual Report 2021

Language: English

View Annual Report
Thumbnail BeOne Medicines Annual Report 2020

Annual Report 2020

Language: English

View Annual Report
Thumbnail BeOne Medicines Annual Report 2019

Annual Report 2019

Language: English

View Annual Report
Thumbnail BeOne Medicines Annual Report 2018

Annual Report 2018

Language: English

View Annual Report
Thumbnail BeOne Medicines Annual Report 2017

Annual Report 2017

Language: English

View Annual Report
Thumbnail BeOne Medicines Annual Report 2016

Annual Report 2016

Language: English

View Annual Report